Seeking Alpha

Neoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA...

Neoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA for its cancer detection platform Lymphoseek. The company seeks clearance to market it for use in surgical oncology procedures.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|